medigraphic.com

2009, Number S1

<< Back Next >>

Rev Mex Anest 2009; 32 (S1)

Perioperative care of the patient with a cardiac pacemaker or ICD

Rozner MA

Language: Spanish
References: 77
Page: 190-197
PDF size: 97.43 Kb.


Text Extraction

Preoperative key points

• Have the pacemaker or defibrillator interrogated by a competent authority shortly before the anesthetic.
• Obtain a copy of this interrogation. Ensure that the device will pace the heart.
• Consider replacing any device near its elective replacement period in a patient scheduled to undergo either a major surgery or surgery within 25 cm of the generator.
• Determine the patient’s underlying rhythm/rate to determine the need for backup pacing support.
• Identify the magnet rate and rhythm, if a magnet mode is present and magnet use is planned.
• Program minute ventilation rate responsiveness off, if present.
• Program all rate enhancements off.
• Consider increasing the pacing rate to optimize oxygen delivery to tissues for major cases.
• Disable antitachycardia therapy if a defibrillator.


REFERENCES

  1. Rasmussen MJ, Friedman PA, Hammill SC, Rea RF. Unintentional deactivation of implantable cardioverter-defibrillators in health care settings. Mayo Clin Proc 2002;77:855-9.

  2. Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. Anesthesiology 2005;103:186-98.

  3. Fleisher, Lee A, Beckman, Joshua A, Brown, Kenneth A, Calkins, Hugh, Chaikof, Elliott, Fleischmann, Kirsten E, Freeman, William K, Froehlich, James B, Kasper, Edward K, Kersten, Judy R, Riegel, Barbara, Robb, John F. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation Published 9/27/07. Available at: http://circ.ahajournals.org/cgi/content/short/116/17/e418. Accessed 4/1/09.

  4. Goldschlager N, Epstein A, Friedman P, Gang E, Krol R, Olshansky B. Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment. Arch Intern Med 2001;161:649-55.

  5. Pinski SL, Trohman RG. Interference in implanted cardiac devices, part I. Pacing Clin Electrophysiol 2002;25:1367-81.

  6. Pinski SL, Trohman RG. Interference in implanted cardiac devices, part II. Pacing Clin Electrophysiol 2002;25:1496-509.

  7. Stevenson WG, Chaitman BR, Ellenbogen KA, et al. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists. Circulation 2004;110:3866-69.

  8. Medtronic. Important patient management information (Sigma series pacemakers). Published 11/05. Available at: http://www. medtronic.com/crmLetter.html. Accessed 4/8/09.

  9. Guidant Insignia Pacemakers. Product Advisories. Published 9/22/05. Available at: http://www.bostonscientific.com/templatedata/imports/HTML/PPR/ppr/support/current_advisories.pdf. Accessed 4/9/09.

  10. Guidant PDM Pacemakers. Product Advisories. Published 7/18/05. Available at: http://www.bostonscientific.com/templatedata/imports/HTML/PPR/ppr/support/current_advisori es.pdf. Accessed 4/8/09.

  11. Medtronic. ICD recall. Published 2/10/05. Available at: http://www.plaintiffsadvocate.com/marquis/recall.pdf(site taken down). Accessed 4/8/09.

  12. Guidant Contak Renewal [H135, H155 ICD. Product Advisories. Published 6/17/05. Available at: http://www.bostonscientific.com/templatedata/imports/HTML/PPR/ppr/support/current_advisori es.pdf. Accessed 4/8/09.

  13. Guidant Prizm 2 [1861] ICD. Product Advisories. Published 6/17/05. Available at: http://www.bostonscientific.com/templatedata/imports/HTML/PPR/ppr/support/current_advisori es.pdf. Accessed 4/8/09.

  14. Guidant Contak Renewal [3, 4 RF ICD magnet switch. Product Advisories. Published 6/23/05. Available at: http://www. bostonscientific.com/templatedata/imports/HTML/PPR/ppr/support/current_advisori es.pdf. Accessed 4/8/09.

  15. Maisel WH, Moynahan M, Zuckerman BD, et al. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA 2006;295:1901-6.

  16. Kazatsker M, Kusniek J, Hasdai D, Battler A, Birnbaum Y. Two pacemakers in one patient: a stimulating case. J Cardiovasc Electrophysiol 2002;13:522.

  17. Cheng A, Nazarian S, Spragg DD, et al. Effects of surgical and endoscopic electrocautery on modern-day permanent pacemaker and implantable cardioverter-defibrillator systems. Pacing Clin Electrophysiol 2008;31:344-50.

  18. Pili-Floury S, Farah E, Samain E, Schauvliege F, Marty J. Perioperative outcome of pacemaker patients undergoing non-cardiac surgery. Eur J Anaesthesiol 2008;25:514-16.

  19. Rozner MA, Roberson JC, Nguyen AD. Unexpected High Incidence of Serious Pacemaker Problems Detected by Pre-and Postoperative Interrogations: A Two-Year Experience. J Am Coll Cardiol 2004;43:113A.

  20. Lamas GA, Rebecca GS, Braunwald NS, Antman EM. Pacemaker malfunction after nitrous oxide anesthesia. Am J Cardiol 1985;56:995.

  21. Bernstein AD, Daubert JC, Fletcher RD et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol 2002;25:260-264.

  22. Delfaut P, Saksena S. Electrophysiologic assessment in selecting patients for multisite atrial pacing. J Interv Card Electrophysiol 2000;4:81-85.

  23. Peters RW, Gold MR. Pacing for patients with congestive heart failure and dilated cardiomyopathy. Cardiol Clin 2000;18:55-66.

  24. Abraham WT, Fisher WG, Smith AL et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.

  25. Hare JM. Cardiac-resynchronization therapy for heart failure. N Engl J Med 2002;346:1902-5.

  26. Atlee J, Bernstein A. Cardiac rhythm management devices part I. Anesthesiology 2001;95:1265-80.

  27. Gras D, Mabo P, Tang T, et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol 1998;21:2249-55.

  28. Medina-Ravell VA, Lankipalli RS, Yan GX, et al. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 2003;107:740-746.

  29. Rozner MA, Gursoy S, Monir G. Care of the patient with a pacemaker. In: Stone DJ, Bogdanoff DL, Leisure GS, Spiekermann BF, Mathis DD, eds. Perioperative care: anesthesia, surgery and medicine. Philadelphia: Mosby; 1997:53-67.

  30. Purday JP, Towey RM. Apparent pacemaker failure caused by activation of ventricular threshold test by a magnetic instrument mat during general anaesthesia. Br J Anaesth 1992;69:645-46.

  31. Bourke ME. The patient with a pacemaker or related device. Can J Anaesth 1996;43:24-41.

  32. Valls-Bertault V, Mansourati J, Gilard M, Etienne Y, Munier S, Blanc JJ. Adverse events with transvenous left ventricular pacing in patients with severe heart failure: early experience from a single centre. Europace 2001;3:60-63.

  33. Alonso C, Leclercq C, d’Allonnes FR et al. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects. Heart 2001;86:405-10.

  34. Bernstein AD, Irwin ME, Parsonnet V et al. Report of the NASPE Policy Conference on antibradycardia pacemaker follow-up: effectiveness, needs, and resources. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol 1994;17:1714-29.

  35. Hayes JJ, Juknavorian R, Maloney JD. The role(s) of the industry employed allied professional. Pacing Clin Electrophysiol 2001;24:398-99.

  36. Preisman S, Cheng DC. Life-threatening ventricular dysrhythmias with inadvertent asynchronous temporary pacing after cardiac surgery. Anesthesiology 1999;91:880-883.

  37. Andersen C, Madsen GM. Rate-responsive pacemakers and anaesthesia. A consideration of possible implications. Anaesthesia 1990;45:472-76.

  38. Levine PA. Response to «rate-adaptive cardiac pacing: implications of environmental noise during craniotomy». Anesthesiology 1997;87:1261.

  39. Levine PA, Balady GJ, Lazar HL, Belott PH, Roberts AJ. Electrocautery and pacemakers: management of the paced patient subject to electrocautery. Ann Thorac Surg 1986;41:313-17.

  40. Rozner MA, Nguyen AD. Unexpected pacing threshold changes during non-implant surgery. Anesthesiology 2002;96:A1070.

  41. Levine PA. Clinical utility of automatic capture algorithms. In: Tse H-F, Lee KL, Lau C-P. Eds. Proceedings of the XII world congress on cardiac pacing and electrophysiology. Bologna, Italy: Medimond International Proceedings; 2003:601-608.

  42. Madsen GM, Andersen C. Pacemaker-induced tachycardia during general anaesthesia: a case report. Br J Anaesth 1989;63:360-361.

  43. von Knobelsdorff G, Goerig M, Nagele H, Scholz J. [Interaction of frequency-adaptive pacemakers and anesthetic management. Discussion of current literature and two case reports].

  44. Anaesthesist 1996;45:856-60.

  45. Van Hemel NM, Hamerlijnck RP, Pronk KJ, Van der Veen EP. Upper limit ventricular stimulation in respiratory rate responsive pacing due to electrocautery. Pacing Clin Electrophysiol 1989;12:1720-3.

  46. Wong DT, Middleton W. Electrocautery-induced tachycardia in a rate-responsive pacemaker. Anesthesiology 2001;94:710-1.

  47. Chew EW, Troughear RH, Kuchar DL, Thorburn CW. Inappropriate rate change in minute ventilation rate responsive pacemakers due to interference by cardiac monitors. Pacing Clin Electrophysiol 1997;20:276-82.

  48. Rozner MA, Nishman RJ. Pacemaker-driven tachycardia revisited. Anesth Analg 1999;88:965.

  49. Wallden J, Gupta A, Carlsen HO. Supraventricular tachycardia induced by Datex patient monitoring system. Anesth Analg 1998;86:1339.

  50. Interaction between minute ventilation rate-adaptive pacemakers and cardiac monitoring and diagnostic equipment. Center for Devices and Radiologic Health. Published 10/14/98. Available at: http://www.fda.gov/cdrh/safety/minutevent.html. Accessed 4/8/09.

  51. Southorn PA, Kamath GS, Vasdev GM, Hayes DL. Monitoring equipment induced tachycardia in patients with minute ventilation rate-responsive pacemakers. Br J Anaesth 2000;84:508-9.

  52. Rozner MA, Nishman RJ. Electrocautery-induced pacemaker tachycardia: why does this error continue? Anesthesiology 2002;96:773-4.

  53. Lau W, Corcoran SJ, Mond HG. Pacemaker tachycardia in a minute ventilation rate-adaptive pacemaker induced by electrocardiographic monitoring. Pacing Clin Electrophysiol 2006;29: 438-40.

  54. Pressly, N. Review of MDR Reports reinforces concern about EMI. FDA User Facility Reporting #20. Published 97. Available at: http://www.fda.gov/cdrh/fuse20.pdf. Accessed 4/8/09.

  55. Rozner MA. Review of electrical interference in implanted cardiac devices. Pacing Clin Electrophysiol 2003;26:923-25.

  56. Trankina MF, Black S, Gibby G. Pacemakers: Perioperative evaluation, management and complications. Anesthesiology 2000;93: A1193.

  57. Michaloudis D, Fraidakis O, Lefaki T, Kanakoudis F, Askitopoulou H. Anaesthesia and the QT interval in humans: effects of halothane and isoflurane in premedicated children. Eur J Anaesthesiol 1998;15:623-28.

  58. Gallagher JD, Weindling SN, Anderson G, Fillinger MP. Effects of sevoflurane on QT interval in a patient with congenital long QT syndrome. Anesthesiology 1998;89:1569-73.

  59. Paventi S, Santevecchi A, Ranieri R. Effects of sevoflurane versus propofol on QT interval. Minerva Anestesiol 2001;67: 637-40.

  60. Yildirim H, Adanir T, Atay A, Katircioglu K, Savaci S. The effects of sevoflurane, isoflurane and desflurane on QT interval of the ECG. Eur J Anaesthesiol 2004;21:566-70.

  61. Mychaskiw G, Eichhorn JH. Interaction of an implanted pacemaker with a transesophageal atrial pacemaker: report of a case. J Clin Anesth 1999;11:669-71.

  62. Moskowitz DM, Kahn RA, Camunas J, Marin ML, Hollier LH. External chest wall stimulation to suppress a permanent transvenous pacemaker in a patient during endovascular stent graft placement. Anesthesiology 1998;89:531-33.

  63. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.

  64. AVID Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-83.

  65. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341:1882-90.

  66. Moss A, Zareba W, Hall W, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.

  67. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.

  68. Bernstein AD, Camm AJ, Fisher JD, et al. North American Society of Pacing and Electrophysiology policy statement. The NASPE/BPEG defibrillator code. Pacing Clin Electrophysiol 1993;16:1776-80.

  69. Swerdlow CD. Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: state-of-the-art review. J Cardiovasc Electrophysiol 2001;12:606-12.

  70. Hurst TM, Krieglstein H, Tillmanns H, Waldecker B. Inappropriate management of selfterminating ventricular arrhythmias by implantable cardioverter defibrillators despite a specific reconfirmation algorithm: a report of two cases. Pacing Clin Electrophysiol 1997;20:1328-31.

  71. Prasad K, Kishore AG, Anderson MH et al. Inappropriate shocks in patients receiving internal cardioverter-defibrillators for malignant ventricular arrhythmias. Indian Heart J 1997;49:403-7.

  72. Schumacher B, Tebbenjohanns J, Jung W, Korte T, Pfeiffer D, Luderitz B. Radiofrequency catheter ablation of atrial flutter that elicits inappropriate implantable cardioverter defibrillator discharge. Pacing Clin Electrophysiol 1997;20:125-27.

  73. Rozner MA. The patient with an implantable cardioverter-defibrillator. Progress in Anesthesiology 1999;13:43-52.

  74. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator - The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-23.

  75. Rozner M.A. Management of implanted cardiac defibrillators during eye surgery. Anes Analg 2008;106:671-72.

  76. Ellenbogen KA, Wood MA, Shepard RK, et al. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol 2003;41:73-80.

  77. Varma N, Cunningham D, Falk R. Central venous access resulting in selective failure of ICD defibrillation capacity. Pacing Clin Electrophysiol 2001;24:394-95.




2020     |     www.medigraphic.com